Peptides DB
Research-centric peptide and protocol reference hub
Study 10 of 13BAM-15 literaturebiorxiv-preprint · Observational2026

Human GPR174 deficiency drives polyclonal lymphoproliferative disease via defects in T cell function

GPR174 deficiency may lead to dysregulated T cell responses, contributing to conditions like lymphadenopathy and autoimmunity.

Read at biorxiv-preprintAdd to compare

Where it sits

this study against the rest of the bam-15 corpus
0
Preclinical
13
Observational · this one
0
Open-label
0
Randomised
0
Reviews

Summary and findings

Six individuals with function-disrupting variants in GPR174 were studied, revealing a clinical phenotype of lymphadenopathy and autoimmunity. Histological analysis showed necrotizing lymphadenitis and lymphoproliferation resembling Kikuchi-Fujimoto disease. The study suggests that GPR174 loss may predispose individuals to exaggerated lymphoproliferation and autoimmunity following viral infection.

How much of this paper we could read: full text read (0.80). We had a clear abstract, so the summary below closely tracks the paper. What this means →
Not reported in abstract.2026

Abstract

The authors’ words, as biorxiv-preprint supplied them

The X-linked G-protein coupled receptor GPR174 is highly expressed in T and B lymphocytes and has immunoregulatory roles in mice, but its function in humans is unknown. We describe a cohort of six individuals who have function-disrupting variants in GPR174 and a clinical phenotype of lymphadenopathy and autoimmunity. Histological analysis of two patient lymph nodes revealed necrotizing lymphadenitis and lymphoproliferation resembling Kikuchi-Fujimoto disease. In-depth analysis of three patients and related carriers revealed overaccumulation of CD8 terminally differentiated effector memory cells re-expressing CD45RA (T EMRA ). Patient cells and GPR174- deficient CD8 T cells generated from controls showed less repression of proliferation by the GPR174 ligand lysophosphatidylserine (lysoPS) and an effector-biased gene expression program. GPR174-deficient CD4 T cells were resistant to lysoPS-mediated suppression of IL2 production. In mice, chronic viral infection led to over-accumulation of GPR174-deficient effector CD8 T cells. We describe an inborn error of immunity associated with dysregulated lymphocyte responses that we propose predisposes to exaggerated lymphoproliferation and autoimmunity following viral infection. <h4>Summary</h4> Six individuals with function-disrupting variants in the G-protein coupled receptor GPR174 provide insight into its immunoregulatory role. GPR174 loss emerges as a potential genetic risk factor for histiocytic necrotizing lymphadenitis (Kikuchi-Fujimoto disease) and autoimmunity via defects in T cell regulation.

Background

Not reported in abstract.

Methods

Not reported in abstract.

Results

Not reported in abstract.

Interpretation

Not reported in abstract.

Limitations

  • Not reported in abstract.

Elsewhere in the BAM-15 corpus

BMicroRNA expression profile of fibro-adipogenic progenitors in Duchenne muscular dystrophy reveals dysregulation of adipogenesis-related microRNAsbiorxiv-preprint · 2026 · Not reported in abstract.HumanDGuidance for clinical variant classification in genes for spliceosomal small nuclear RNAsbiorxiv-preprint · 2026 · ∼50-fold increase in de novo mutation rate in snRNA genes compared to intergenic sequence.reviewBTowards a complete characterization of common human polymorphic inversions and their functional effectsbiorxiv-preprint · 2026 · ∼20% of inversions are in high linkage disequilibrium with GWAS signals.HumanBMutation timing, accumulation and selection in the male germline shape inheritance risk for developmental disordersbiorxiv-preprint · 2026 · Global dN/dS of 1.56 (95% CI 1.45–1.67) compared to 1.44 (95% CI 1.17–1.77) in controls.HumanBA genome-wide deletion map in 125,730 individuals for novel rare disease gene and variant discoverybiorxiv-preprint · 2026 · 213Mb or 6.92% of the human genome covered by these deletions.HumanBThe Role of Network Connectivity and Transcriptomic Vulnerability in Shaping Grey Matter Atrophy in Multiple Sclerosisbiorxiv-preprint · 2026 · Not reported in abstract.Human